WHO ICTRP trial
Comparative study between Liposomal Amphoterisin B and Miltefosine in post kala…
CTRI/2018/06/014579 · Clinical Trials Registry India (CTRI) · Recruiting
Key facts
| Trial ID | CTRI/2018/06/014579 |
|---|---|
| Public title | Comparative study between Liposomal Amphoterisin B and Miltefosine in post kala azar dermal Leishmaniasis |
| Scientific title | An Observational, prospective, comparative study of the effectiveness and safety of Liposomal Amphotericin-B versus Miltefosine in the treatment of Post Kala-Azar Dermal Leishmaniasis (PKDL). |
| Primary sponsor | Department of Pharmacology |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Recruiting |
| Study type | Observational |
| Phase | Post Marketing Surveillance |
| Countries | India |
| Conditions | Health Condition 1: null- Suffering from Post Kala Azar Dermal Leishmaniasis |
| Registration date | Jun 20, 2018 |
| Target size | 100 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: